Drosomycin-like defensin, a human homologue of Drosophila melanogaster drosomycin with antifungal activity.

Antimicrobial Agents and Chemotherapy
Anna SimonMihai G Netea

Abstract

Innate antifungal defense in Drosophila melanogaster relies on the activation of the Toll molecule and the release of drosomycin, a defensin-like molecule with antifungal properties. Ten human homologues of Toll have been described, with central roles in activation of the innate host defense. In the present study, we report a putative human homologue of the Drosophila-derived drosomycin, designated drosomycin-like defensin (DLD). Synthetic DLD displays a broad spectrum of activity against Aspergillus spp. and other clinically relevant filamentous fungi. These effects are specific for filamentous fungi; no activity has been found against yeasts or gram-positive or gram-negative bacteria. Synthetic DLD also displays immunomodulatory effects on Aspergillus-stimulated cytokine production. In addition, we show the expression of DLD mRNA in several human tissues, particularly in the skin, consistent with its putative role as a defensin against invading microorganisms. This is the first indication of an endogenous human peptide with specific antifungal activity, which is probably central in the defense against infections with molds.

References

Jan 1, 1995·DNA Sequence : the Journal of DNA Sequencing and Mapping·M ZolloE Y Chen
Jan 22, 1998·Proceedings of the National Academy of Sciences of the United States of America·F L RockJ F Bazan
Feb 27, 1999·Current Opinion in Immunology·R I Lehrer, T Ganz
Feb 23, 2000·The Journal of Clinical Investigation·E LienD T Golenbock
Nov 18, 2000·The Journal of Peptide Research : Official Journal of the American Peptide Society·C LandonP Sodano
May 7, 2002·The Journal of Infectious Diseases·Mihai G NeteaBart Jan Kullberg
Jul 6, 2002·Science·Petros LigoxygakisJean-Marc Reichhart
Jan 14, 2003·Annual Review of Immunology·Kiyoshi TakedaShizuo Akira
Apr 12, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Yuko Tsutsumi-Ishii, Isao Nagaoka
Nov 7, 2003·Nature·Jules A Hoffmann
Jan 30, 2004·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·T J WalshE Anaissie
Feb 24, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Silvia BellocchioLuigina Romani
Aug 1, 1997·Trends in Cell Biology·J A Hergannan, J V Rechhart

❮ Previous
Next ❯

Citations

Jun 28, 2008·Proceedings of the National Academy of Sciences of the United States of America·Georgios ChamilosDimitrios P Kontoyiannis
Mar 3, 2009·Medical Mycology·D Yang, J J Oppenheim
Jul 2, 2014·Cell Biochemistry and Biophysics·Carlos PolancoMarili Leopold-Sordo
May 16, 2014·Pharmaceuticals·Guangshun Wang
Jul 25, 2012·Journal of Insect Physiology·Sarah H Merkling, Ronald P van Rij
Jul 21, 2009·Microbes and Infection·Viviane Balloy, Michel Chignard
Jul 8, 2008·Current Opinion in Microbiology·Frank L van de VeerdonkMihai G Netea
Oct 12, 2011·Immunological Investigations·Ronen Ben-Ami
Jul 26, 2012·The Journal of Infectious Diseases·Stefanie S V HenrietAdilia Warris
Jan 22, 2010·Nature·Thomas BeckerMichael Hoch
Mar 27, 2010·Letters in Applied Microbiology·Y JiangM Li
Apr 30, 2021·Frontiers in Cell and Developmental Biology·Caroline StruyfsKarin Thevissen
Jun 29, 2021·Evolutionary Applications·Binia De CahsanRalph Tiedemann

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Related Papers

European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
A LupettiP H Nibbering
The Journal of Biological Chemistry
Salamatu S MambulaStuart M Levitz
© 2021 Meta ULC. All rights reserved